Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > W Mark Hahn > Profile

W Mark Hahn

Affiliations

  • Chief Financial Officer at Verona Pharma Plc (VRNA), 2025-06-13
  • Director at Alsp Orchid Acquisition Corp I (ALOR), 2021-11-18
  • Chief Financial Officer at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
  • Evp And Cfo at Cempra Inc. (CEMP), 2017-02-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DOVA $6.28 2,500 $15,700.00 2,500 2018-12-19 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VRNA $11.40 400,000 $4,560,360.00 12,278,992 2025-06-11 Filing
VRNA $9.33 204,864 $1,911,667.93 12,678,992 2025-05-29 Filing
VRNA $9.30 162,704 $1,513,293.63 12,883,856 2025-05-28 Filing
VRNA $9.53 32,432 $308,982.91 13,046,560 2025-05-27 Filing
VRNA $9.09 400,000 $3,637,720.00 13,078,992 2025-05-02 Filing